The Effects of Tamoxifen and Fish Oil on Mammary Carcinogenesis in Polyoma Middle T Transgenic Mice

Hormones and Cancer

Volumn 2, Issue 4, 2011, Pages 249-259

  Manni, Andrea ^a,c   Xu, Haifang ^a   Washington, Sharlene ^a   Aliaga, Cesar ^a   Das, Arunangshu ^a   Cooper, Timothy ^a   Richie Jr , John P ^a   Prokopczyk, Bogdan ^a   Calcagnotto, Ana ^a   Trushin, Neil ^a   Van den Heuvel, John P ^b   Hamilton, Christopher ^a   Demers, Laurence M ^a   Liao, Jason ^a   Verderame, Michael F ^a   El Bayoumy, Karam ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Fish oil; Mammary carcinogenesis; Polyoma Middle T; Tamoxifen

Indexed keywords

ARACHIDONIC ACID; CORN OIL; ESTROGEN RECEPTOR; FISH OIL; HORMONE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN F2 ALPHA; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG INHIBITION; FEMALE; GENE EXPRESSION; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR VOLUME;

ANIMALS; ESTROGEN RECEPTOR ALPHA; FEMALE; FISH OILS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; POLYOMAVIRUS; PPAR GAMMA; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TUMOR VIRUS INFECTIONS;

EID: 79960959565     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-011-0078-2     Document Type: Article

References (29)

1. Allred DC, Mohsin SK, Fuqua SA (2001) Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8: 47-61.
2. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388.
3. Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. Jama 281: 2189-2197.
4. Osborne CK, Shou J, Massarweh S, Schiff R (2005) Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 11: 865s-870s.
5. Johnston SR (2005) Combinations of endocrine and biological agents: present status of therapeutic and presurgical investigations. Clin Cancer Res 11: 889s-899s.
6. Manni A, Xu H, Washington S, Aliaga C, Cooper T, Richie JP Jr, Bruggeman R, Prokopczyk B, Calcagnotto A, Trushin N, Mauger D, Verderame MF, El-Bayoumy K (2010) The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. Cancer Prev Res 3: 322-330.
7. Bonofiglio D, Gabriele S, Aquila S, Catalano S, Gentile M, Middea E, Giordano F, Ando S (2005) Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. Clin Cancer Res 11: 6139-6147.
8. Wang X, Kilgore MW (2002) Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 194: 123-133.
9. MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, Lim YW, Traina SB, Hilton L, Garland R, Morton SC (2006) Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295: 403-415.
10. Ruxton CH, Reed SC, Simpson MJ, Millington KJ (2007) The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 20: 275-285.
11. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW (2003) Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 163: 2113-2126.
12. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954-961.
13. Lepage G, Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27: 114-120.
14. Gopinathan L, Hannon DB, Smith Iii RW, Peters JM, Vanden Heuvel JP (2008) Regulation of peroxisome proliferator-activated receptors by e6-associated protein. PPAR Res 2008: 746935.
15. Wallen WJ, Belanger MP, Wittnich C (2001) Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats. J Nutr 131: 2351-2357.
16. Wallen WJ, Belanger MP, Wittnich C (2002) Body weight and food intake profiles are modulated by sex hormones and tamoxifen in chronically hypertensive rats. J Nutr 132: 2246-2250.
17. Greaves P, Goonetilleke R, Nunn G, Topham J, Orton T (1993) Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res 53: 3919-3924.
18. Cohen LA, Chen-Backlund JY, Sepkovic DW, Sugie S (1993) Effect of varying proportions of dietary menhaden and corn oil on experimental rat mammary tumor promotion. Lipids 28: 449-456.
19. Wei N, Wang B, Zhang QY, Mi MT, Zhu JD, Yu XP, Yuan JL, Chen K, Wang J, Chang H (2008) Effects of different dietary fatty acids on the fatty acid compositions and the expression of lipid metabolic-related genes in mammary tumor tissues of rats. Nutr Cancer 60: 810-825.
20. Edwards IJ, Berquin IM, Yong QC, O'Flaherty JT (2010) w-3 PUFAs, breast and prostate cancer: experimental studies. In: Calviello G, Serini S (eds) Dietary omega-3 polyunsaturated fatty acids and cancer. Springer, Berlin, pp 167-188.
21. Sawyer MB, Field CJ (2010) Possible mechanisms of w-3 PUFA anti-tumor action. In: Calviello G, Serini S (eds) Dietary omega-3 polyunsaturated fatty acids and cancer. Springer, Berlin, pp 3-38.
22. Dabrosin C, Palmer K, Muller WJ, Gauldie J (2003) Estradiol promotes growth and angiogenesis in polyoma middle T transgenic mouse mammary tumor explants. Breast Cancer Res Treat 78: 1-6.
23. Rondinelli RH, Haslam SZ, Fluck MM (1995) The role of ovarian hormones, age and mammary gland development in polyomavirus mammary tumorigenesis. Oncogene 11: 1817-1827.
24. Menard S, Aiello P, Tagliabue E, Rumio C, Lollini PL, Colnaghi MI, Balsari A (2000) Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model. Cancer Res 60: 273-275.
25. Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Iezzi M, Ricci C, Astolfi A, Croci S, Marangoni F, Musiani P, Forni G, Lollini PL (2003) Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12. Int J Cancer 105: 384-389.
26. Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P (2005) Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis. Cancer Res 65: 3493-3496.
27. Sasaki T, Kobayashi Y, Shimizu J, Wada M, In'nami S, Kanke Y, Takita T (1998) Effects of dietary n-3-to-n-6 polyunsaturated fatty acid ratio on mammary carcinogenesis in rats. Nutr Cancer 30: 137-143.
28. Yee LD, Young DC, Rosol TJ, Vanbuskirk AM, Clinton SK (2005) Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone. J Nutr 135: 983-988.
29. Olivo SE, Hilakivi-Clarke L (2005) Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis. Carcinogenesis 26: 1563-1572.